Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albrecht von Brunn

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Virology|September 1, 2015
Editorial overview: Engineering for viral resistanceAlbrecht von Brunn
Medicine in Drug Discovery|August 25, 2020
Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19Chenglong Liu, Albrecht von Brunn, Di Zhu
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Yeast two-hybrid screens: improvement of array-based screening results by N- and C-terminally tagged fusion proteinsThorsten Stellberger, Roman Häuser, Peter Uetz, et al.
Molecular Biomedicine|November 12, 2021
Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid proteinRenjie Zhou, Rui Zeng, Albrecht von Brunn, et al.
Current Opinion in Virology|October 13, 2012
Virus-host interactomes--antiviral drug discoveryYue Ma-Lauer, Jian Lei, Rolf Hilgenfeld, et al.
Infection|April 11, 2020
SARS-CoV-2 and Europe: timing of containment measures for outbreak controlChenyu Li, Paola Romagnani, Albrecht von Brunn, et al.
Biochemical and Biophysical Research Communications|May 5, 2011
Crystal structure of the middle domain of human poly(A)-binding protein-interacting protein 1Jian Lei, Jeroen R Mesters, Albrecht von Brunn, et al.
Current Opinion in Virology|August 31, 2015
Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replicationAlbrecht von Brunn, Sandra Ciesek, Brigitte von Brunn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 11, 2020
Cyclosporine and COVID-19: Risk or favorable?Nadia Nicholine Poulsen, Albrecht von Brunn, Mads Hornum, et al.
Virus Research|November 2, 2022
Corrigendum to 'Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506' Virus Research (2012) 165/1 [112-117]: CorrigendumJavier Carbajo-Lozoya, Marcel A Müller, Stephan Kallies, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Virology|September 1, 2015
Editorial overview: Engineering for viral resistanceAlbrecht von Brunn
Medicine in Drug Discovery|August 25, 2020
Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19Chenglong Liu, Albrecht von Brunn, Di Zhu
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
Yeast two-hybrid screens: improvement of array-based screening results by N- and C-terminally tagged fusion proteinsThorsten Stellberger, Roman Häuser, Peter Uetz, et al.
Molecular Biomedicine|November 12, 2021
Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid proteinRenjie Zhou, Rui Zeng, Albrecht von Brunn, et al.
Current Opinion in Virology|October 13, 2012
Virus-host interactomes--antiviral drug discoveryYue Ma-Lauer, Jian Lei, Rolf Hilgenfeld, et al.
Infection|April 11, 2020
SARS-CoV-2 and Europe: timing of containment measures for outbreak controlChenyu Li, Paola Romagnani, Albrecht von Brunn, et al.
Biochemical and Biophysical Research Communications|May 5, 2011
Crystal structure of the middle domain of human poly(A)-binding protein-interacting protein 1Jian Lei, Jeroen R Mesters, Albrecht von Brunn, et al.
Current Opinion in Virology|August 31, 2015
Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replicationAlbrecht von Brunn, Sandra Ciesek, Brigitte von Brunn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 11, 2020
Cyclosporine and COVID-19: Risk or favorable?Nadia Nicholine Poulsen, Albrecht von Brunn, Mads Hornum, et al.
Virus Research|November 2, 2022
Corrigendum to 'Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506' Virus Research (2012) 165/1 [112-117]: CorrigendumJavier Carbajo-Lozoya, Marcel A Müller, Stephan Kallies, et al.
Pageof 4